Suppr超能文献

挥发物组学作为确定女性不孕症潜在生物标志物的新兴策略:一项初步研究。

Volatilomics as an Emerging Strategy to Determine Potential Biomarkers of Female Infertility: A Pilot Study.

作者信息

Brinca Ana Teresa, Anjos Ofélia, Alves Maria Manuel Casteleiro, Sousa Ângela, Oliani António Hélio, Breitenfeld Luiza, Passarinha Luís A, Ramalhinho Ana Cristina, Gallardo Eugenia

机构信息

Health Sciences Research Centre, Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.

Instituto Politécnico de Castelo Branco, Quinta da Senhora de Mércules, 6001-909 Castelo Branco, Portugal.

出版信息

Biomedicines. 2022 Nov 8;10(11):2852. doi: 10.3390/biomedicines10112852.

Abstract

Due to its high prevalence, infertility has become a prominent public health issue, posing a significant challenge to modern reproductive medicine. Some clinical conditions that lead to female infertility include polycystic ovary syndrome (PCOS), endometriosis, and premature ovarian failure (POF). Follicular fluid (FF) is the biological matrix that has the most contact with the oocyte and can, therefore, be used as a predictor of its quality. Volatilomics has emerged as a non-invasive, straightforward, affordable, and simple method for characterizing various diseases and determining the effectiveness of their current therapies. In order to find potential biomarkers of infertility, this study set out to determine the volatomic pattern of the follicular fluid from patients with PCOS, endometriosis, and POF. The chromatographic data integration was performed through solid-phase microextraction (SPME), followed by gas chromatography-mass spectrometry (GC-MS). The findings pointed to specific metabolite patterns as potential biomarkers for the studied diseases. These open the door for further research into the relevant metabolomic pathways to enhance infertility knowledge and diagnostic tools. An extended investigation may, however, produce a new mechanistic understanding of the pathophysiology of the diseases.

摘要

由于其高发性,不孕症已成为一个突出的公共卫生问题,对现代生殖医学构成了重大挑战。一些导致女性不孕的临床病症包括多囊卵巢综合征(PCOS)、子宫内膜异位症和卵巢早衰(POF)。卵泡液(FF)是与卵母细胞接触最密切的生物基质,因此可作为其质量的预测指标。挥发物组学已成为一种用于表征各种疾病并确定其当前治疗效果的非侵入性、直接、经济且简单的方法。为了寻找不孕症的潜在生物标志物,本研究着手确定PCOS、子宫内膜异位症和POF患者卵泡液的挥发物组模式。通过固相微萃取(SPME)进行色谱数据整合,随后进行气相色谱-质谱联用(GC-MS)分析。研究结果指出特定的代谢物模式可作为所研究疾病的潜在生物标志物。这些发现为进一步研究相关代谢组学途径以增进对不孕症的了解和改进诊断工具打开了大门。然而,进一步的研究可能会对这些疾病的病理生理学产生新的机制性认识。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/1ae0/9687186/0a3188b414a8/biomedicines-10-02852-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验